Results obtained by Zou et al. revealed that overexpression of TPX2 is associated with the progression of prostate cancer and a poor prognosis in patients, whereas Pan et al. demonstrated that targeting TPX2 suppressed the proliferation of human prostate carcinoma cells [10, 11]. This evidence concerns the gene TPX2 and Familial prostate cancer.